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Objectives: to investigate the inflammatory response within intact carotid plaques from carotid eversion endarterectomy
(CEE) to determine the relationship between immunohistological plaque morphology and ischaemic cerebrovascular
symptoms.
Material and methods: intact CEE plaques from 71 patients with high-grade (>70%) stenosis undergoing CEE (group
I, symptomatic, n=42; group II, asymptomatic, n=29) and 12 normal postmortem arteries (control group) were analysed
with specific antibodies to inflammatory cells (T-Lymphocytes (CD3, CD4), cytotoxic T-cells (CD8), B-lymphocytes
(CD20), natural killer cells (CD57), macrophages (CD68)), endothelial adhesion molecules (ICAM-1 (CD54), P-selectin
(CD62P), E-selectin (CD62E), VCAM-1 (CD106) and T-lymphocyte co-stimulatory molecule (CD40)) and procoagulatory
modulators (thrombomodulin (CD141), tissue factor (CD142)). Both groups were matched for gender, age, risk factors,
degree of carotid artery stenosis. Plaques were measured using a semiquantitative score system in a blinded fashion by
two observers. Statistical analysis of the group differences were performed by using the Kruskal–Wallis test and the
Multitest Procedure with Permutation-Testing. Significance was taken as a p<0.05.
Results: there were significantly more inflammatory cells, an overexpression of P-selectin and the procoagulatory markers
thrombomodulin and tissue factor in symptomatic compared to both asymptomatic plaques and the ones of the control
group. In both groups there was no significance for ICAM-1, VCAM-1, macrophages and co-stimulatory molecule CD40.
There was also no significance for any factor between the asymptomatic and the control group. However, the differences
between the symptomatic and the asymptomatic group were highly significant for all factors.
Conclusion: these data suggest that structural changes and inflammatory damage within the individual plaque seems to
be a critical step in promoting plaque rupture with embolic sequelae.
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Introduction asymptomatic severe carotid stenosis has been con-
firmed.4
Those data suggest two different types of underlyingThe great majority of strokes associated with carotid
carotid artery disease: a stable form and the unstableartery disease result from embolisation from an ath-
plaque at risk for embolisation. The atheroscleroticerosclerotic plaque rather than from hypoperfusion
carotid artery stenosis is a complex and dynamic bio-due to high-grade carotid artery stenosis (i.e. >70%
logical process. Recent studies have shown that plaqueluminal narrowing). Using published data from the
morphology is associated with plaque rupture andNorth American Symptomatic Carotid En-
consecutive embolisation.5–7 Chronic inflammation isdarterectomy Trial (NASCET),1 the European Carotid
an integral part of atherosclerosis. Human athero-Surgery Trial (ECST),2 and the Asymptomatic Carotid
sclerotic plaques contain large numbers of macro-Atherosclerosis Study (ACAS),3 there is a clearly in-
phages and also significant amounts of activated T-creasing stroke risk with severity of stenosis resulting
lymphocytes.8,9 However, complete immuno-in a highly variable annual risk up to 13%. The low
histochemical plaque characterisation is still lackingrisk of stroke (1–2%) associated with clinically
and the biologic basis for those clinical observations
has yet to be clearly determined. Local and systemic
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factors (autoimmunity or infection) that influenceof Vascular Surgery, Ruprecht-Karls University, Kirschnerstrasse 1,
D-69120 Heidelberg, Germany. plaque stability are uncertain.
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Table 1. Patients’ demographics.
Symptomatic Asymptomatic
patients patients
(n=42) (n=29)
Age (years)∗ 66±8 66±9
Sex (Male) 30 (72%) 16 (55%)
Smoking 21 (50%) 4 (14%)
Fig. 1. Carotid endarterectomy specimen (total length 35 mm): intactHypertension 33 (79%) 24 (83%)
freshly harvested cylinder without any endothelial damage due toDiabetes 14 (33%) 7 (24%)
eversion technique.Hypercholesteraemia 17 (41%) 10 (34%)
Coronary artery disease 16 (38%) 9 (31%)
∗Data expressed as mean±s.d.
The aim of our present study was to investigate
the vascular biology underlying those differences in
plaque stability comparing the cells involved and the
local inflammatory response with immuno-
histochemistry of plaques removed from symptomatic
and asymptomatic patients. An understanding of those
processes of plaque destabilisation could influence
treatment strategies and patient selection to identify
patients at particularly high risk of stroke.
Material and Methods
Patients
Fig. 2. Cross-section of eversion specimen (diameter 9 mm) with
plaque ulceration on the right side.This prospective study included 71 patients who
underwent carotid endarterectomy: 46 men and 25
women; mean age, 66 years (range 40–88 years). All revealed carotid artery stenosis. They served as tissue
had haemodynamically significant carotid bifurcation samples for the “baseline-expression” of the examined
disease, as determined by ultrasound: mean 86% factors on human carotid vessels.
(range 70–99%) admitted to undergo for extracranial
high-grade ICA stenosis. All carotid eversion en-
darterectomy procedures (routine procedure) were
performed by one group of vascular surgeons at the Carotid eversion endarterectomy specimens
Department of Vascular Surgery of the Ruprecht–Karls
University Heidelberg, during a 10-month period. After excision of the internal carotid artery from the
bifurcation, the completely intact specimen was har-Antiplatelet drugs had not been used for more than
7 days. All patients were evaluated carefully by a vested by the vascular surgeon (routine eversion tech-
nique) (Fig. 1). The fresh carotid eversion specimenneurologist. Using NASCET criteria, 42 of the 71 en-
rolled patients were “symptomatic” based on a history (CES) was rinsed briefly in saline to remove surface
blood and transported in physiological 0.9% salineof recent occurrence of transient retinal (n=4) or
cerebral (n=26) symptoms or minor ischaemic stroke directly after CEE. It was fixed immediately after
dividing into three tissue blocks (Fig. 2): one block for(n=12) and 29 patients were asymptomatic. Risk fac-
tors for carotid bifurcation disease were recorded for conventional histology (fixed in 10% buffered para-
formaldehyde), the second for immunohistochemistryall patients (Table 1).
Informed consent was obtained. and the third part for future research with electronic
microscopy (fixed in glutaraldehyde). After em-Postmortem carotid arteries obtained from 12 aut-
opsies served as controls: 7 men and 5 women; mean bedding in paraffin and stained with haematoxylin
and eosin (H&E) and elastic van Gieson (EVG) aage 63 (range 26–88) years. None of the specimens
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Table 2. Antibodies used for immunohistochemistry.
Antibody Antigen Type Source Clone Solution
CD 3 T-lymphocytes Mab Loxo UCHT-1 1:100
CD 4 T-helper cells Mab Dako MT-310 1:50
CD 8 Cytotoxic T-lymphocytes Mab Loxo UCHT-4 1:50
CD 20 B-lymphocytes Mab Dako L 26 1:50
CD 40 Co-stimulatory molecule for T-lymphocytes Mab Dianova E3 1:50
CD 54 ICAM-1 Mab Zymed MY-13 1:50
CD 57 Natural killer cells Mab Loxo NK-1 1:50
CD 62E E-selectin Mab R&D BBA-18 1:200
CD 62P P-selectin Mab Dako 1E3 1:50
CD 68 Macrophages Mab Dako PG-M1 1:50
CD 106 VCAM-1 Mab R&D BBA-19 1:200
CD 141 Thrombomodulin Mab Dako 1009 1:100
CD 142 Tissue factor Mab Cedarlane AB11-64R 1:250
ICAM-1, Intercellular Adhesion Molecule 1; VCAM-1, Vascular Cell Adhesion Molecule 1; Mab, monoclonal antibody; Dako, Carpenteria,
California; Cedarlane, Hornby, Ontario; Dianova, Hamburg, Germany; R&D, Wiesbaden, Germany; Zymed, San Francisco, California.
pathologist examined sections form each specimen in unspecific staining. Then the monoclonal antibody
order to assess the histological integrity of the speci- was used (solutions are listed in Table 1). After
men. Five patients, whose CES could not be used incubation at room temperature for 1 h the slides
because of histological disruption or strong cal- were washed 2× in TRIS-buffer and then incubated
cification not allowing preparation for im- with a second IgG-solution against unspecific staining
munochemistry, were excluded from the study and resulting from the second antibody. Therefore, 20%
do not appear in the total number of 71 patients. After normal serum taken from the species of which the
decalcification, the whole specimen was transversely second antibody originated was used. For CD 142,
sectioned at 3–4 mm intervals and the plaque was donkey-anti-sheep-antibodies (DIANOVA) were used
divided into several parts with regard to its individual in a dilution of 1:1500. A second biotinylated antibody
length (from 0.8 cm to 2.9 cm) (Fig. 2). A 2 cm segment (LINK (5%); BIO GENEX, San Ramon, CA, U.S.A.),
of the postmortem carotid arteries (6 left carotid ar- was used except for CD62E and CD106 stained
teries; 6 right carotid arteries) was excised en bloc from sections, where anti-goat-antibodies (from rabbits)
the bifurcation downstream. were applied in a dilution of 1:400. For CD142-
staining, the first block mentioned above was used.
After washing again for 2× in TRIS-buffer, all
slides were incubated with a streptavidin-alkaline-Immunohistochemical analysis
phosphatase-complex (LABEL (2%), BIO GENEX) for
30 min. Fast Red-system (DAKO) was used in orderFor immunocyto- and histochemistry, serial 4-m sec-
to visualise antibody-binding to the specific struc-tions from each block were cut throughout the plaque
tures. All sections were counterstained with haema-from each of the 85 frozen samples mounted onto
toxylin. For negative controls, the application of thegelatin-coated slides. After washing with 100% acet-
primary antibody was omitted. As positive controlsone, the cryo-sections were microwaved and incubated
tissue samples of human tonsils were used forwith monoclonal antibodies against antigens of in-
all antibodies. Antigen expression was measuredfiltrating inflammatory cells, endothelial adhesion
semiquantitatively by a score from 0 to 3 in stepsmolecules and co-stimulatory molecules for T-Lym-
of 0.5. Reference sections were used to classifyphocytes (CD40) as well as procoagulatory mod-
sections of one series. For each possible score aulators. The cell-type specific antibodies used to
reference slide was selected from the specific stainingidentify individual cell types are listed in Table 2. The
series (for example CD8). This means that thereantigen staining was highly specific for all applied
were 7 categories (0, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0) underantibodies. With the used antibodies, no cross-re-
which a single slide taken from this specific stainingactivity was observed. The following procedure was
series was categorized. Evaluation was repeated fourused: after fixation in acetone (100%) for 10 min the
times. The examiner was blind to the clinical history.slides were incubated with human IgG (g-Venin; 1 mg/
The mean value was calculated and statistical analysisml), Bovine Serum Albumine (20 mg/ml) and CAS-
block (ZYMED) for 15 min in order to prevent was performed.
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Fig. 3. Immunohistochemical staining of macrophages (CD 68)
within a symptomatic plaque.
Antibodies
The following primary and secondary monoclonal
antibodies were used for immunohistochemistry
(Table 2).
Statistical analysis
Quantitative non-parametric continuous variables
were expressed as mean values and were compared
by using the Kruskal–Wallis test. A p-value less than
0.05 was considered significant. Group differences
were assessed with a Multivariable Testing Procedure
with Permutation Test to compare the expression of
each antigen within one group with that of the other
groups. This statistical procedure is more suitable than
a Mann–Whitney U-test with Bonferroni-correction
factor in this situation as our data did not show a
normal distribution for the expression of all factors
examined.
Results
Immunohistochemical analysis revealed significant
inflammatory response and cell infiltration in all
specimens examined, although interindividually to
a highly variable degree, compared to the control
group of postmortem arteries. Immunohistochemical
findings are summarised in Table 3. Immuno-
phenotyping of the cellular components of the
plaques and the expression of adhesion molecule
P-selectin were described and significant for the
symptomatic plaques. The carotid plaque is a viable
and active biological system. In symptomatic patients
we clearly found significant local inflammatory re-
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Fig. 4. Immunohistochemical staining of the endothelial adhesion
molecule ICAM-1 (CD 54) on the inner surface of a symptomatic
plaque.
Fig. 6. Immunohistochemical staining of the adhesion molecule P-
selectin (CD 62P) of a symptomatic plaque.
control group. There was significant increase in
the expression of endothelial adhesion molecule P-
selectin and a higher rate of infiltrating inflammatory
cells into the plaque (Figs 3–6). Within the symp-
tomatic group the modulators of procoagulatory
response thrombomodulin and tissue factor were
also significantly increased in comparison to both
the asymptomatic as well as the control group.
Discussion
At present, the main criterion used to decide whether
a patient should be considered for carotid end-
arterectomy or not, is the degree of stenosis for both
symptomatic and asymptomatic patients.9 In ran-
domised controlled studies was clearly shown that
the degree of stenosis was the only criterion which
correlates with stroke, although the presence of ul-Fig. 5. Immunohistochemical staining of T lymphocytes (CD 3)
within a symptomatic plaque. cerated plaques on angiography also has increased the
Eur J Vasc Endovasc Surg Vol 21, June 2001
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Fig. 7. The inflammatory response in carotid bifurcation disease.
risk in the NASCET Trial.1,10 Carotid endarterectomy there was no statistically significant difference between
the degree of stenosis in symptomatic and asympto-decreased the risk of ipsilateral ischaemic stroke by a
factor of six in those patients with severe stenosis matic patients. However, the natural histories of
equally severe symptomatic and asymptomatic carotid70–99% in the internal carotid artery. In our study
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stenoses are very different, which suggests char- in vivo using radiolabelled antibodies to macrophages
or adhesion molecules. Future studies investigatingacteristic plaque features and active vascular biology
within the symptomatic plaque.11–16 Leucocyte re- the recruitment of inflammatory cells and release of
mediators may lead to pharmacological strategies ofcruitment depends on the expression of endothelial
adhesion molecules on the intimal surface.17 Firm ad- plaque stabilisation.
On immunophenotyping the carotid eversion speci-hesion requires binding of leukocyte CD18 and endo-
thelial adhesion molecules such as intercellular mens, according to the literature, plaque morphology
and increased local inflammatory response do correlateadhesion molecule-1 (ICAM-1) and vascular cellular
adhesion molecule-1 (VCAM-1). The expression of with the initial neurological clinical presentation com-
pared with asymptomatic patients. These findings sug-these adhesion molecules has been studied in our
specimens, and expression of P-selectin, E-selectin, gest that plaque morphology plays an important role
in the presentation of carotid artery disease (Fig. 7).ICAM-1, and VCAM-1 could be correlated with high
density of macrophages and T-lymphocytes in the
carotid plaques.18 It is uncertain by which route leuco-
cytes enter the plaque. On plaque rupture, exposure Acknowledgements
of the necrotic core to the circulation promotes throm-
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